A phase II basket study of MCLA-128, a bispecific antibody targeting the HER3 pathway, in NRG1 fusion-positive advanced solid tumours

A. M. Schram, A. Drilon, T. Macarulla Mercade, E. M. O'Reilly, J. A. Rodon, B. M. Wolpin, S-H. I. Ou, D-W. Kim, J. C-H. Yang, Y. C. J. Lam, A. Varga, A. J. de Langen, P. O. Witteveen, V. Boni, G. Cerea, M. Duruisseaux, S. V. Liu, E. Wasserman, D. M. Hyman, J. Tabernero

Research output: Contribution to journal › Meeting Abstract › Academic

Fingerprint

Dive into the research topics of 'A phase II basket study of MCLA-128, a bispecific antibody targeting the HER3 pathway, in NRG1 fusion-positive advanced solid tumours'. Together they form a unique fingerprint.

Medicine & Life Sciences